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Avian necrotic enteritis is a major economic and welfare issue throughout the global poultry industry and is caused
by isolates of Clostridium perfringens that produce NetB toxin. Previously we have shown that birds directly
vaccinated with inactivated C. perfringens type A culture supernatant (toxoid) combined with recombinant NetB
(rNetB) protein were significantly protected from homologous and heterologous challenge. In the present study the
protective effect of maternal immunization was examined. Broiler breeder hens were injected subcutaneously with
genetically toxoided rNetB(S254L) alone, C. perfringens type A toxoid and toxoid combined with rNetB(S254L).
Vaccination resulted in a strong serum immunoglobulin Y response to NetB in hens immunized with rNetB(S254L)
formulations. Anti-NetB antibodies were transferred to the eggs and on into the hatched progeny. Subclinical
necrotic enteritis was induced experimentally in the progeny and the occurrence of specific necrotic enteritis
lesions evaluated. Birds derived from hens immunized with rNetB(S254L) combined with toxoid and challenged
with a homologous strain (EHE-NE18) at either 14 or 21 days post-hatch had significantly lower levels of disease
compared to birds from adjuvant only vaccinated hens. In addition, birds from hens immunized with rNetB(S254L)
alone were significantly protected when challenged at 14 days post-hatch. These results demonstrate that maternal
immunization with a NetB-enhanced toxoid vaccine is a promising method for the control of necrotic enteritis in
young broiler chickens.Introduction
Necrotic enteritis in chickens has become a major welfare
and economic issue for the global poultry industry in
recent years [1]. Necrotic enteritis is a complex enteric
disease and the causative agent is the Gram-positive,
spore-forming bacterium Clostridium perfringens. The
primary method of disease control has been to use iono-
phore anticoccidials or in-feed antibiotics [2]. However,
there is global concern that these practices increase
the level of bacterial antibiotic resistance [3]. Therefore,
it has become increasingly important to develop new* Correspondence: anthony.keyburn@csiro.au
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stated.interventions for this disease, including the development
of vaccines.
Clostridial vaccines in other livestock animals, including
cattle, sheep and pigs, have been available for many de-
cades [4], but an effective vaccine for necrotic enteritis in
chickens remains limited with only one vaccine, Netvax®,
currently commercially available. This vaccine is based on
an alpha-toxin toxoid prepared from a C. perfringens type
A strain isolated from a cow (CN 1491 alternately called
ATCC 13124) [5]. Other experimental vaccines based on
alpha-toxin have been evaluated with variable protective
success [6–8] and other partially protective C. perfringens
antigens have been identified [9]. Recently, several stud-
ies have demonstrated that the major toxin produced by
pathogenic isolates of avian necrotic enteritis-derived
C. perfringens, NetB, is an effective vaccine antigen
[10–12]. These studies all demonstrated some protective
efficacy when NetB was used as a single subunit vaccine,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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bination with other cellular and/or secreted antigens
gave far greater protection against both homologous
and heterologous challenge than any of the components
used separately [12]. While these studies demonstrated
that NetB based vaccines are effective in protecting
birds from disease the delivery of the vaccines by direct
vaccination of broiler chicks, is not a practical vaccin-
ation regime for the poultry industry. Attempts to vac-
cinate chickens at one day of age were not successful
[13]. Maternal vaccination, by which broiler breeder
hens are vaccinated to induce protection in the progeny,
is a more efficient method of mass vaccinating large
numbers of young birds.
For maternal vaccination to be successful antibodies
passed from a vaccinated hen into the egg and the
hatched chick must be capable of protecting the chicks
from disease. The protective immune response mecha-
nisms acting in parenteral vaccinated birds are not well
understood. There are no clear studies that directly ad-
dress the issue of whether passively transferred immun-
ity can confer protection from disease. Two previously
reported studies used C. perfringens toxoid vaccines in
maternal vaccination trials and found some protection
from necrotic enteritis. In one study [14] no details are
provided regarding the origin of the strains used to pro-
duce the toxoids and in the other study [5] no details
are given regarding the source of the toxoid, although a
search of product registration documents reveals the
strain to be derived from a cow rather than a chicken
and not likely to have specific proteins involved in disease,
such as NetB and host specific adhesions. The authors of
each study suggested that antibodies against alpha-toxin
were probably a significant protective factor. We hypothe-
sized that if vaccines based on alpha-toxin, which is non-
essential for virulence [15], could provide some level of
protection from disease when maternally-delivered then
maternal vaccines based on the essential virulence factor,
NetB, should deliver enhanced efficacy.
Previously recombinant NetB was chemically toxoided
for use in vaccines [12]. By using a mutated version of NetB
with reduced toxic activity the need for chemical toxoiding
can be avoided. Other workers [11] demonstrated that a
genetically toxoided version of NetB(W262A) had similar
efficacy in vaccination as wild-type recombinant NetB. A
structural and mutational analysis of NetB has identified
other amino acids that are important for toxic activity [16].
The substitution of serine residue 254 with leucine resulted
in defective homo-oligomerization in solution and the
mutant protein was no longer haemolytic against chicken
and duck red blood cells.
The objective of this present study was to evaluate
maternal immunization of vaccines containing NetB for
the protection of broiler chickens from necrotic enteritis.We also determined serum IgY antibody responses to
NetB in broiler breeder hens after immunization with
genetically toxoided rNetB(S254L) alone or in combin-
ation with the other C. perfringens proteins present in
culture supernatant (toxoid), and the transfer of NetB-
specific antibody into progeny. Finally, the progeny
were challenged in a disease induction model to evalu-




C. perfringens strain EHE-NE18 [15] was the challenge
strain in the in vivo necrotic enteritis disease induction
models and was used to prepare the toxoid for vaccine
formulations.
Animals and housing conditions
Twenty-week-old Ross 308 broiler breeder birds were
supplied by Aviagen Australia and managed following
the standard guidelines provided by the hatchery. The
birds were housed in groups of 12 hens with 2 roosters
per group. Immediately prior to the first vaccination blood
samples were taken (wing brachial vein) and serum tested
for anti-NetB specific IgY to determine whether there had
been pre-exposure to this antigen. The hens were vacci-
nated subcutaneously at 22, 24 and 26 weeks of age. Blood
and eggs were collected at 30 weeks (four weeks after the
third vaccination) and serum and yolk anti-NetB specific
IgY levels measured. Blood was also collected at 40 weeks
for anti-NetB IgY measurement.
Fertilized eggs for Challenge Trial 1 were collected
throughout week 31 and for Challenge Trial 2 through-
out week 41. Eggs were stored at 17 °C throughout the
collection period and then transferred to an incubator
(Wesfan 924, WA, Australia) and then into a hatcher
(Bellsouth, VIC, Australia) at day 18 till hatch.
Vaccination
The toxoid was prepared as previously described [12]. Re-
combinant NetB(S254L) (rNetB(S254L)) was expressed
and purified as previously described [16]. Fifty μg of rNetB
(S254L) per dose per bird was used for NetB subunit and
NetB supplemented toxoid vaccines. The vaccines were
prepared in CSIRO triple adjuvant (60% (v/v) Montanide,
40% (v/v) antigen combined with Quil A, 3 mg/mL, and
DEAE-dextran, 30 mg/mL in PBS) to a total volume of
500 μL per dose.
To assess the efficacy of the vaccines in the progeny
from immunized hens at two susceptible time points
(days 14 to 21), two challenge trials were carried out. In
trial 1, fertile eggs were collected five weeks after the
third vaccination (31 weeks old hens) and the progeny
were challenged at days 21 and 22 followed by necropsy
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after the third vaccination (41 weeks old hens) and birds
were challenged one week earlier than in trial 1 (chal-
lenged at day 14 and 15 followed by necropsy at day 16).
In both trials there were 25 birds per group.
Necrotic enteritis disease induction model
Necrotic enteritis was induced using the C. perfringens
in-feed infection model as previously described [12].
Twenty-five chicks for each vaccine group were housed
in adjacent, but separate, pens in an animal isolation fa-
cility. To assess the disease status of each chicken the
birds were euthanized with inhaled carbon dioxide and
small intestines (duodenum to ileum) were examined for
gross necrotic lesions. Intestinal lesions in the small in-
testine were scored as before [15]: 0 = no gross lesions;
1 = thin or friable walls; 2 = focal necrosis or ulceration
(1–5 foci); 3 = focal necrosis or ulceration (6–15 foci);
4 = focal necrosis or ulceration (16 or more foci); 5 =
patches of necrosis 2–3 cm long; 6 = diffuse necrosis
typical of field cases. The lesion data were analysed using
Kruskal-Wallis one-way ANOVA to determine the likeli-
hood that the vaccinated groups had different levels of
disease compared to the adjuvant control group. A blood
sample was taken from all birds immediately before
challenge and serum was analysed by enzyme-linked im-
munosorbent assay (ELISA) to measure anti-NetB IgY
antibody levels. All animal experiments were assessed,
approved and monitored by the Australian Animal
Health Laboratory’s Animal Ethics Committee.
Immunoassay detection of antibodies
NetB-specific antibody levels in serum were determined
by the end-point dilution method using an ELISA as(a)
Figure 1 Serum IgY antibody levels against C. perfringens NetB in hen
anti-NetB specific IgY antibodies were measured by ELISA and expressed a
The error bars represent SEM. (a) Serum anti-NetB IgY levels of vaccinated
anti-NetB IgY levels of vaccinated hens at 40 weeks of age (14 weeks post-described previously [12]. IgY antibodies were extracted
from egg yolk as previously described [17], with some
modifications. Briefly, the yolk was separated from the
albumin and PBS was added at 1:1 ratio. The yolk was
then vortexed till it reached a uniformly dispersed solu-
tion and was then homogenised for 30 min on a rotating
wheel. The solution was centrifuged at 3000 g for 25 min
and supernatant containing the IgY collected. The sam-
ples were diluted 1:1600 in 1% BSA in PBS and 0.1 mL
per well was used in the anti-NetB IgY ELISA.
Results
Antibody transfer from vaccinated hens to progeny
In broiler breeder hens, prior to the first vaccination, the
mean anti-NetB IgY antibodies were at low, background
levels in all birds (data not shown). Following three vacci-
nations the mean anti-NetB specific IgY antibody levels
significantly increased in birds vaccinated with rNetB
(S254L) (p < 0.05 at both 30 and 40 weeks; Figure 1a) and
the toxoid supplemented with rNetB(S254L) (p < 0.05 and
p < 0.01 at 30 and 40 weeks respectively; Figure 1b). Mean
anti-NetB specific IgY antibodies of hens in the control
(adjuvant only) and toxoid alone groups remained low
throughout the study.
Fertilized eggs were collected at 30 weeks and tested for
the transfer of anti-NetB specific IgY antibodies into the
eggs. Higher anti-NetB specific IgY antibody levels were
observed in eggs from rNetB(S254L) or Toxoid + rNetB
(S254L) vaccinated hens compared to eggs from adjuvant
control vaccinated hens (p < 0.001; Figure 2). Surprisingly,
the level of anti-NetB specific IgY antibodies was also
significant in eggs from hens vaccinated with toxoid
alone (p < 0.01), despite the serum levels in the hens
being similar to the adjuvant control hens. While the(b)
s after sub-cutaneous immunization with vaccines. The levels of
s the average optical density at 450 nm of the standard dilution used.
hens at 30 weeks of age (4 weeks post final vaccination). (b) Serum
final vaccination). *p < 0.05, **p < 0.01.
Figure 2 Egg yolk anti-NetB IgY levels. Fertilized eggs were
collected from immunized hens at 30 weeks and specific antibodies
derived from the egg yolk measured by ELISA. The error bars
represent SEM. **p < 0.01, ***p < 0.001.
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it was not unexpected that the toxoid group had specific
antibodies since the toxoid will have low levels of native
NetB because it was made using a virulent strain that
produces this toxin.
The anti-NetB specific IgY levels in hatched chicks
from vaccinated hens were assessed prior to challenge
in the first trial (21 days of age; Figure 3a). The anti-
NetB specific IgY antibody levels were significantly higher
in those chicks from hens vaccinated with rNetB(S254L)
alone (p < 0.05) or toxoid + rNetB(S254L) (p < 0.001) com-
pared to the adjuvant control chicks. However, unlike the
anti-NetB specific IgY antibody levels in eggs, the toxoid(a)
Figure 3 Maternally derived anti-NetB specific IgY antibodies in prog
(b) anti-NetB IgY levels in a separate group of 14 day-old chickens. Error baalone group of chicks did not have significantly higher
levels than the adjuvant control birds (p > 0.1).
The anti-NetB specific IgY antibodies of chicks hatched
from vaccinated hens for trial two were also assessed
(14 days of age; Figure 3b). As before, the rNetB(S254L)
and Toxoid + rNetB(S254L) groups had significantly
higher levels of anti-NetB specific IgY antibodies than
the adjuvant group (p < 0.001). However, unlike in the
first trial, the toxoid group also had significantly higher
levels of anti-NetB specific IgY antibodies compared the
adjuvant control birds (p < 0.001). The difference in
anti-NetB specific IgY antibody levels between the two
trials could be attributed to the earlier time point of
collection of the pre-challenge blood samples from the
chicks (14 days compared to 21 days).Transferred antibodies partially protect birds from
necrotic enteritis
In trial one, in which birds were challenged at 21 days
post-hatch, the toxoid + rNetB(S254L) vaccinated group
had a 50% reduction in the number of birds with lesions
(Table 1) and a significant reduction (54%) in average
lesion score (p < 0.01) compared to the adjuvant control
group (Figure 4a). However, neither the rNetB(S254L)
nor the toxoid alone groups were protected compared
to the adjuvant control group.
In trial two birds were challenged at a younger age; at
14 days post-hatch. Similar to trial one, the toxoid + rNetB
(S254L) group had a reduction in the number of birds
with lesions (62%, Table 1) and a highly significant reduc-
tion (73%) in mean lesion score (p < 0.001) compared to
the adjuvant control group (Figure 4b). However, unlike
trial one, both the rNetB(S254L) and toxoid alone groups
also had fewer birds with lesions (52% and 33% reduction,
respectively) and a significant reduction in average lesion(b)
eny chickens. (a) Anti-NetB IgY levels in 21 day-old chickens;
rs represent SEM. *p < 0.05, ***p < 0.001.
Table 1 Summary of trial results
Trial Group Birds with NE Average lesion
score ± SEMa
Reduction in number
of birds with NE (%)
Reduction in group
average lesion score (%)
1 Adjuvant 22/25 2.6 ± 0.3 -
NetB(S254L) 23/25 2.1 ± 0.2 −4.5 19
Toxoid 16/25 1.8 ± 0.3 27 31
Toxoid + NetB(S254L) 11/25 1.2 ± 0.3** 50 54
2 Adjuvant 21/25 3.0 ± 0.3 -
NetB(S254L) 10/25 1.0 ± 0.3*** 52 67
Toxoid 14/25 1.6 ± 0.3* 33 47
Toxoid + NetB(S254L) 8/25 0.8 ± 0.3*** 62 73
aTreatment groups were compared to adjuvant control group using Kruskal-Wallis one-way ANOVA with Dunns post test *denotes p < 0.05; **denotes p < 0.01;
***denotes p < 0.001.
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the adjuvant control group.
Discussion
This is the first study to demonstrate that passive trans-
fer of antibodies from hens vaccinated with NetB-based
vaccines can protect progeny from necrotic enteritis at
the peak ages of disease susceptibility. It is anticipated
that such vaccines would provide a valuable tool for the
prevention of necrotic enteritis under field conditions.
Previous studies that have investigated passive immunity
against necrotic enteritis have been based on vaccines
to induce alpha-toxin antibodies [5,14]. Although alpha-
toxin vaccines can clearly provide some level of protection,
both when used to directly vaccinate birds and when used
for maternal vaccination, the antigen is not an essential
virulence factor in the pathogenesis of necrotic enteritis
[15]. We hypothesized that using the important necrotic
enteritis virulence factor NetB, as either a single subunit(a) (b
Figure 4 Lesion scores in C. perfringens challenged progeny chickens
Each symbol represents an individual bird. (a) Trial 1: chickens challenged a
represent SEM. n = 25 per group. *p < 0.05, **p < 0.01, ***p < 0.001.vaccine or to enhance a conventional clostridial toxoid
vaccine, was likely to provide higher levels of protection
than alpha-toxin based vaccines.
The origins of the strains used to produce the maternal
toxoid vaccines used in the study reported by Lovland
et al. [14] are not reported and the C. perfringens strain
used to generate the toxoid tested in the Crouch et al.
study [5] was isolated from a cow. While this strain pro-
duces a large quantity of alpha-toxin [18] it most likely
lacks other proteins involved in pathogenesis in chick-
ens, including NetB. There is evidence that the choice
of C. perfringens strain used for toxoid production is
likely to influence the degree of protection that can be
induced. The most direct evidence for this is the different
degrees of efficacy noted by Lanckriet et al. [19] when
comparing toxoids prepared from different strains. The
importance of using chicken isolates of C. perfringens for
vaccine preparation is supported by the finding of other
potential virulence factors genetically linked to netB, a)
. The horizontal bars represent the average lesion score in each group.
t day 21. (b) Trial 2 - chickens challenged at day 14. Error bars
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The strain used to generate the toxoid in this current
study (EHE-NE18) is a strain that was isolated from a
chicken with necrotic enteritis and is capable of causing
disease under experimental conditions [15,22]. This strain
not only produces alpha-toxin but also produces other
proteins involved in disease, including NetB. It is therefore
likely to contain a greater range of relevant antigens in
toxoid preparations. Although EHE-NE18 does produce
NetB, the level of the toxin produced under the in vitro
culture conditions used in this current study was generally
not sufficient to induce a strong anti-NetB immune
response in vaccinated hens compared to the adjuvant
control (Figure 1a). The addition of rNetB(S254L) to
the toxoid preparation significantly increased the anti-
NetB antibody levels in the hens and these antibody
levels were also significantly higher in the chicks hatched
from vaccinated hens (Figure 3). Transfer of specific anti-
bodies is essential for the protection of young birds, since
their immune system is not fully developed, especially the
gut-associated lymphoid tissue, the maturation of which is
not complete until two weeks of age [23]. The vaccination
regime used in this study incorporated three vaccinations
across six weeks with the final vaccination occurring when
the hens were 26 weeks old. Although we saw no evidence
of a drop of egg production in this study (data not shown)
this vaccination regime is unlikely be the regime adopted
by the poultry industry. Similar to other vaccines used in
broiler breeders by the industry, the final vaccine most
likely would be administered within the first 18 weeks post
hatch to ensure that there is no impact on egg production.
Maternally derived antibodies in the progeny are at
maximal levels at the time of hatch and gradually reduce
in concentration as the birds mature. The key to the
success of a maternal vaccination protocol is to ensure
that there are sufficient antibodies circulating at the crit-
ical period when the birds are most susceptible to disease.
The peak period when necrotic enteritis is a problem in
broiler chickens is between 2 to 6 weeks post-hatch [24],
hence we tested vaccine efficacy following challenge
within this this critical period. Significant protection was
seen in the progeny from hens vaccinated with toxoid plus
rNetB(S254L) when challenged with a homologous strain
(EHE-NE18) in-feed at day 14 and 21 (Figures 4a and b).
Surprisingly, given previous results with directly vacci-
nated birds [12], significant protection was observed
against in-feed challenge in the birds vaccinated with
rNetB(S254L) alone (p < 0.001) and toxoid alone (p < 0.05)
when challenged at 14 days (Figure 4b). This result may
be due to higher levels of specific antibodies at the time of
challenge, although the difference between the serum
levels of rNetB(S254L) and toxoid at the time of challenge
was not significant (p > 0.1). Even though significant pro-
tection was seen in progeny from hens vaccinated withrNetB(S254L) alone and toxoid alone at 14 days, only
birds from toxoid plus rNetB(S254L) hens were signifi-
cantly protected at both 14 and 21 days.
In conclusion, it has been shown that vaccination of
broiler breeders with a C. perfringens toxoid preparation
derived from a chicken necrotic enteritis strain and en-
hanced by the addition of non-toxic rNetB(S254L) protein,
followed by subsequent transfer of maternal immunity
to their progeny, provides significant protection against
necrotic enteritis. The ease of delivery indicates that this
type of vaccine may be a suitable candidate for use in
the poultry industry in the near future.
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